This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004:15 Suppl 4:iv267-73.

doi: 10.1093/annonc/mdh937.

Head and neck cancer

L Licitra¹, L D Locati, P Bossi

Affiliations

PMID: 15477319
DOI: 10.1093/annonc/mdh937

Free article

Review

Head and neck cancer

L Licitra et al. Ann Oncol. 2004.

Free article

. 2004:15 Suppl 4:iv267-73.

doi: 10.1093/annonc/mdh937.

Authors

L Licitra¹, L D Locati, P Bossi

Affiliation

¹ Head and Neck Cancer Medical Oncology Unit, Cancer Medicine Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

PMID: 15477319
DOI: 10.1093/annonc/mdh937

No abstract available

PubMed Disclaimer

Similar articles

Treatment of head and neck cancer.
Tobias JS. Tobias JS. N Engl J Med. 1998 Oct 29;339(18):1330-1. N Engl J Med. 1998. PMID: 9841300 No abstract available.
Treatment of head and neck cancer.
Rescigno J, Heitjan DF. Rescigno J, et al. N Engl J Med. 1998 Oct 29;339(18):1330; author reply 1331. N Engl J Med. 1998. PMID: 9841299 No abstract available.
Intensified concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
Alastuey I. Alastuey I. J Clin Oncol. 1995 May;13(5):1281-2. doi: 10.1200/JCO.1995.13.5.1281. J Clin Oncol. 1995. PMID: 7738633 No abstract available.
Medical treatment in head and neck cancer.
Vermorken JB. Vermorken JB. Ann Oncol. 2005;16 Suppl 2:ii258-64. doi: 10.1093/annonc/mdi735. Ann Oncol. 2005. PMID: 15958469 Review. No abstract available.
Chemotherapy in head and neck tumors.
Dos Santos MC. Dos Santos MC. Rev Paul Med. 1993 Jul-Aug;111(4):54-8. Rev Paul Med. 1993. PMID: 8108650 Review. No abstract available.

See all similar articles

Cited by

The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications.
Zimmermann M, Zouhair A, Azria D, Ozsahin M. Zimmermann M, et al. Radiat Oncol. 2006 May 2;1:11. doi: 10.1186/1748-717X-1-11. Radiat Oncol. 2006. PMID: 16722544 Free PMC article. Review.
Radiomic Biomarkers of Locoregional Recurrence: Prognostic Insights from Oral Cavity Squamous Cell Carcinoma preoperative CT scans.
Ren L, Ling X, Alexander G, Molitoris J, Choi J, Schumaker L, Mehra R, Gaykalova D. Ren L, et al. Res Sq [Preprint]. 2024 Jan 22:rs.3.rs-3857391. doi: 10.21203/rs.3.rs-3857391/v1. Res Sq. 2024. Update in: Front Oncol. 2024 Apr 23;14:1380599. doi: 10.3389/fonc.2024.1380599. PMID: 38343846 Free PMC article. Updated. Preprint.
Identification of CT based radiomic biomarkers for progression free survival in head and neck squamous cell carcinoma.
Ling X, Bazyar S, Ferris M, Molitoris J, Allor E, Thomas H, Arons D, Schumaker L, Krc R, Mendes WS, Tran PT, Sawant A, Mehra R, Gaykalova DA, Ren L. Ling X, et al. Sci Rep. 2025 Jan 8;15(1):1279. doi: 10.1038/s41598-025-85498-x. Sci Rep. 2025. PMID: 39779914 Free PMC article.
Identification of CT-based non-invasive radiomic biomarkers for overall survival prediction in oral cavity squamous cell carcinoma.
Ling X, Alexander GS, Molitoris J, Choi J, Schumaker L, Mehra R, Gaykalova DA, Ren L. Ling X, et al. Sci Rep. 2023 Dec 8;13(1):21774. doi: 10.1038/s41598-023-48048-x. Sci Rep. 2023. PMID: 38066047 Free PMC article.
CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial-mesenchymal transition via inhibiting MDM2.
Wang X, Li Y, Pan M, Lu T, Wang M, Wang Z, Liu C, Hu G. Wang X, et al. Clin Sci (Lond). 2022 Nov 30;136(22):1691-1710. doi: 10.1042/CS20220581. Clin Sci (Lond). 2022. PMID: 36377775 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information